Key result
Continuous thoracic epidural analgesia significantly decreased narcotic requirements in the PACU (p<0.001) and the first 24 hours after surgery (p<0.001) compared to intravenous pain control.
Why the study?
Does continuous thoracic epidural analgesia reduce opioid use and pain scores compared to intravenous analgesia in patients undergoing laparoscopic abdominal surgery?
Population
Patients undergoing laparoscopic or robot-assisted abdominal surgery
Comparison
Continuous T9-10 thoracic epidural analgesia (TEA) vs Intravenous pain control methods
Design
Case_series
Follow-up
Hospital stay
Authors
Loading...
May support opioid-sparing epidural use in laparoscopic surgery; hypothesis-generating and requires randomized confirmation before practice change.
Observational
No
Does continuous thoracic epidural analgesia reduce opioid use and pain scores compared to intravenous analgesia in patients undergoing laparoscopic abdominal surgery?
p-value: p=<0.001
Continuous thoracic epidural analgesia provides superior pain control and reduces opioid requirements compared to intravenous analgesia following laparoscopic abdominal surgery.
Enten et al. (2018) conducted an observational in Laparoscopic or robot assisted abdominal surgery. Continuous thoracic epidural analgesia (TEA) vs. Intravenous pain control methods was evaluated on Intraoperative, 24 h and post-24 h opioid use in morphine milligram equivalents (MME) (p=<0.001). Continuous thoracic epidural analgesia significantly decreased narcotic requirements in the PACU (p<0.001) and the first 24 hours after surgery (p<0.001) compared to intravenous pain control.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: